Cost-Efficacy Analysis of Fluticasone Propionate versus Zafirlukast in Patients with Persistent Asthma

Author： Menendez R.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.19, Iss.8, 2001-01, pp. : 865-874

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost Effectiveness of Fluticasone Propionate Plus Salmeterol Versus Fluticasone Propionate Plus Montelukast in the Treatment of Persistent Asthma

By Richard D. O’Connor  

PharmacoEconomics, Vol. 22, Iss. 12, 2004-01 ,pp. : 815-825

Adis International

Access to resources Recommend Favorite

Fluticasone propionate more cost effective than zafirlukast for asthma

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 330, 2001-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Fluticasone propionate more cost effective than zafirlukast for asthma

By  

Inpharma, Vol. 1, Iss. 1305, 2001-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Cost-Effectiveness Comparison of Salmeterol/Fluticasone Propionate versus Montelukast in the Treatment of Adults with Persistent Asthma

By Sheth K.  

PharmacoEconomics, Vol. 20, Iss. 13, 2002-01 ,pp. : 909-918

Adis International

Access to resources Recommend Favorite

Cost-Effectiveness and Cost-Utility of Beclomethasone/Formoterol versus Fluticasone Propionate/Salmeterol in Patients with Moderate to Severe Asthma

By Gerzeli Simone  

Clinical Drug Investigation, Vol. 32, Iss. 4, 2012-04 ,pp. : 253-265

Adis International

Access to resources Recommend Favorite